Why change?
作者信息
Hammon John W
出版信息
J Thorac Cardiovasc Surg. 2010 Dec;140(6):1218-9. doi: 10.1016/j.jtcvs.2010.07.012.
PMID:21078424
Abstract
摘要
相似文献
1
Why change?为何要改变？
J Thorac Cardiovasc Surg. 2010 Dec;140(6):1218-9. doi: 10.1016/j.jtcvs.2010.07.012.
2
Membrane polarity: a target for myocardial protection and reduced inflammation in adult and pediatric cardiothoracic surgery.膜极性：成人及小儿心胸外科心肌保护和减轻炎症的靶点。
J Thorac Cardiovasc Surg. 2010 Dec;140(6):1213-7. doi: 10.1016/j.jtcvs.2010.05.040. Epub 2010 Jul 6.
3
Adenosine-procaine cardioplegia and adenosine-lidocaine cardioplegia: Two sides of the same coin?腺苷-普鲁卡因心脏停搏液与腺苷-利多卡因心脏停搏液：同一硬币的两面？
J Thorac Cardiovasc Surg. 2013 Jun;145(6):1684-5. doi: 10.1016/j.jtcvs.2013.01.049.
4
Normokalemic adenosine-lidocaine cardioplegia: importance of maintaining a polarized myocardium for optimal arrest and reanimation.低钾血症腺苷-利多卡因心脏停搏液：维持极化心肌以实现最佳停搏和复律的重要性。
J Thorac Cardiovasc Surg. 2010 Jun;139(6):1576-86. doi: 10.1016/j.jtcvs.2009.10.013. Epub 2010 Feb 4.
5
Retrograde cardioplegia.逆行性心脏停搏液灌注
Adv Card Surg. 1998;10:115-39.
6
The myocardial protective effects of a moderate-potassium adenosine-lidocaine cardioplegia in pediatric cardiac surgery.适度钾含量的腺苷-利多卡因心脏停搏液在小儿心脏手术中的心肌保护作用
J Thorac Cardiovasc Surg. 2008 Dec;136(6):1450-5. doi: 10.1016/j.jtcvs.2008.03.025. Epub 2008 May 19.
7
Advances in myocardial protection: the role of mechanical devices in providing cardioprotective strategies.
Int Anesthesiol Clin. 1996 Spring;34(2):61-84.
8
9
ICVTS on-line discussion A. The safety of using millimolar doses of lidocaine as cardioplegia.国际心胸血管外科学会在线讨论A. 使用毫摩尔剂量利多卡因作为心脏停搏液的安全性。
Interact Cardiovasc Thorac Surg. 2007 Apr;6(2):176. doi: 10.1510/icvts.2006.137240A.
10
Reply to the editor.
J Thorac Cardiovasc Surg. 2013 Jun;145(6):1685-6. doi: 10.1016/j.jtcvs.2013.02.049.
Zotero 插件